UBS has reiterated its "buy" rating for Accenture PLC, with an increased price target of $455.00. This adjustment reflects the positive outlook of analysts regarding the company's performance and market position.
Investors are advised to review potential conflicts of interest related to this analysis, as per relevant EU regulations.
The update was released on December 20, 2024, indicating ongoing confidence in Accenture's growth potential.